Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.Front Immunol. 2020; 11:561851.FI
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
33133071
Citation
Usmani, Salman Sadullah, and Gajendra P S. Raghava. "Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial." Frontiers in Immunology, vol. 11, 2020, p. 561851.
Usmani SS, Raghava GPS. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial. Front Immunol. 2020;11:561851.
Usmani, S. S., & Raghava, G. P. S. (2020). Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial. Frontiers in Immunology, 11, 561851. https://doi.org/10.3389/fimmu.2020.561851
Usmani SS, Raghava GPS. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial. Front Immunol. 2020;11:561851. PubMed PMID: 33133071.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
AU - Usmani,Salman Sadullah,
AU - Raghava,Gajendra P S,
Y1 - 2020/09/29/
PY - 2020/05/13/received
PY - 2020/09/14/accepted
PY - 2020/11/2/entrez
PY - 2020/11/3/pubmed
PY - 2020/11/20/medline
KW - COVID-19
KW - SARS-CoV-2
KW - coronavirus
KW - immunoinformatic
KW - vaccine candidates
SP - 561851
EP - 561851
JF - Frontiers in immunology
JO - Front Immunol
VL - 11
SN - 1664-3224
UR - https://www.unboundmedicine.com/medline/citation/33133071/Potential_Challenges_for_Coronavirus__SARS_CoV_2__Vaccines_Under_Trial_
DB - PRIME
DP - Unbound Medicine
ER -